Lung Fung Group Holdings Limited (HKG:2290)

Market Cap	1.81B
Revenue (ttm)	2.46B +21.8%
Net Income	170.43M
EPS	0.45
Shares Out	500.00M
PE Ratio	7.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,798,000
Open	3.410
Previous Close	3.460
Day's Range	3.400 - 3.780
52-Week Range	2.010 - 4.600
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 29, 2026

About Lung Fung Group Holdings

Lung Fung Group Holdings Limited, through its subsidiaries, sells beauty, health and pharmaceutical products. It offers Chinese and western medicines, health supplements, medical supplies, beauty and skincare products, cosmetics, baby and maternity products, food, fragrances, personal care, and pet food and household daily necessities goods. The company sells its products through retail stores and online sale platforms. The company was founded in 1992 and is headquartered in Fanling, New Territories, Hong Kong. Lung Fung Group Holdings Limited ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1992
• Employees: 694
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2290

Financial Performance

In fiscal year 2025, Lung Fung Group Holdings's revenue was 2.46 billion, an increase of 21.76% compared to the previous year's 2.02 billion. Earnings were 170.43 million, an increase of 17.92%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error